Document ID: chunk:federal_register_of_legislation:F2022C00927:clause:1_1:p1
Version: federal_register_of_legislation:F2022C00927
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 1/3)
Character Range: 13828–17937

1               Definitions
  In this instrument:
                               allergen means an antigenic substance capable of producing an immune response.
                               chronic renal failure means:
         (a)          having a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least three months; or
         (b)          a need for renal replacement therapy (dialysis or transplantation) for treatment of complications of decreased glomerular filtration rate which would otherwise increase the risk of morbidity and mortality; or
         (c)          undergoing chronic dialysis.
                               conjunctivitis—see subsection 7(2).
                               immunocompromised state as specified means a condition of substantially lowered immune function, such as would occur in the following conditions or circumstances:
         (a)          taking an immunosuppressive drug;
         (b)          having a haematological or solid organ malignancy;
         (c)          having chronic renal failure;
         (d)          having infection with human immunodeficiency virus;
         (e)          having severe malnutrition; or
         (f)           undergoing solid organ, stem cell or bone marrow transplantation.
        Note: chronic renal failure and immunosuppressive drug are also defined in the Schedule 1 - Dictionary.
                               immunosuppressive drug means a drug or an agent which results in substantial suppression of immune responses.
Note: Examples of an immunosuppressive drug include:
        (a) chemotherapeutic agents used for the treatment of cancer;
        (b) corticosteroids, other than inhaled or topical corticosteroids;
        (c) drugs used to prevent transplant rejection; or
        (d) a tumour necrosis factor-alpha inhibitor.
                               infection of the conjunctiva means a bacterial, viral, rickettsial, parasitic or fungal infection involving the conjunctiva.
                               injury to the conjunctiva means trauma to the ocular surface involving the conjunctiva by mechanisms including thermal, electrical and chemical burns and blunt or penetrating trauma.
                                  irritant substance means a chemical which causes an inflammatory effect on living tissue by chemical action at the site of contact.
                                  MRCA means the Military Rehabilitation and Compensation Act 2004.
                                  relevant service means:
         (a)          eligible war service (other than operational service) under the VEA;
         (b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
         (c)          peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                               sensitising exposure to an allergen means an exposure to an allergen without the occurrence of symptoms, where the clinical onset of conjunctivitis occurs within the two weeks of a subsequent exposure to the same allergen.
Note: The initial sensitising exposure to an allergen may be either systemic or cutaneous and may have occurred months to years before the re-exposure that has resulted in the conjunctivitis.
                               specified list of conditions means:
         (a)          disorder of nasolacrimal duct or gland;
         (b)          ectropion;
         (c)          exophthalmos; or
         (d)          lid retraction.
                               specified list of drugs means:
         (a)          benzodiazepines;
         (b)          bisphosphonates;
         (c)          celecoxib;
         (d)          chemotherapy for cancer;
         (e)          cyclosporine;
         (f)           dupilumab;
         (g)          fluoxetine;
         (h)          imatinib;
         (i)            isotretinoin;
         (j)            paroxetine;
         (k)          risperidone;
         (l)            tadalafil;
         (m)        topiramate;